DB18604InvestigationalProtein Based Therapies
TPX-4589 is an antibody-drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE.
- Mechanism
- Curator reviewed
Pharmacologically active on Claudin-18
- Also known as
- Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE
- Code names
- LM-302 · TPX-4589
Resolves to
Compound
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with TPX-4589, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account